High-risk human papillomavirus-positive lung cancer: Molecular evidence for a pattern of pulmonary metastasis

Journal of Thoracic Oncology

Volumn 8, Issue 6, 2013, Pages 711-718

  Van Boerdonk, Robert A A ^a   Daniels, Johannes M A ^a   Bloemena, Elisabeth ^a,b   Krijgsman, Oscar ^a   Steenbergen, Renske D M ^a   Brakenhoff, Ruud H ^a   Grünberg, Katrien ^a   Ylstra, Bauke ^a   Meijer, Chris J L M ^a   Smit, Egbert F ^a   Snijders, Peter J F ^a   Heideman, Daniëlle A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Human papillomavirus; Metastatic disease; Non small cell lung cancer; Primary cancer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA;

ADULT; AGED; ARTICLE; CHROMOSOME 20P; CHROMOSOME 3P; CHROMOSOME 4P; CHROMOSOME 9P; FEMALE; GENE DOSAGE; GENOTYPE; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE E7; LUNG CANCER; LUNG CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84879499523     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182897c14     Document Type: Article

References (52)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-781.
2. Alberg AJ, Ford JG, Samet JM; American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):29S-55S. (Pubitemid 47502798)
3. Andres C, Ihrler S, Puchta U, Flaig MJ. Merkel cell polyomavirus is prevalent in a subset of small cell lung cancer: a study of 31 patients. Thorax 2009;64:1007-1008.
4. Giuliani L, Jaxmar T, Casadio C, et al. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer 2007;57:273-281. (Pubitemid 47285415)
5. Joh J, Jenson AB, Moore GD, et al. Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol 2010;89:222-226.
6. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009;384:260-265.
7. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19. (Pubitemid 29406813)
8. Heideman DA, Waterboer T, Pawlita M, et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol 2007;25:4550-4556. (Pubitemid 350035311)
9. Steenbergen RD, de Wilde J, Wilting SM, Brink AA, Snijders PJ, Meijer CJ. HPV-mediated transformation of the anogenital tract. J Clin Virol 2005;32 Suppl 1:S25-S33. (Pubitemid 40332586)
10. Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. Metaanalysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2010;2:15.
11. Lajer CB, von Buchwald C. The role of human papillomavirus in head and neck cancer. APMIS 2010;118:510-519.
12. Rietbergen MM, Leemans CR, Bloemena E, et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 2013;132:1565-1571.
13. Goto A, Li CP, Ota S, et al. Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. J Med Virol 2011;83:1383-1390.
14. Klein F, Amin Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 2009;65:13-18.
15. Koshiol J, Rotunno M, Gillison ML, et al. Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst 2011;103:501-507.
16. Srinivasan M, Taioli E, Ragin CC. Human papillomavirus type 16 and 18 in primary lung cancers-a meta-analysis. Carcinogenesis 2009;30:1722-1728.
17. Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004;14:453-471. (Pubitemid 39360994)
18. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-F78. (Pubitemid 26335492)
19. Münger K, Basile JR, Duensing S, et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001;20:7888-7898. (Pubitemid 33135315)
20. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-1136. (Pubitemid 120035062)
21. Wise-Draper TM, Wells SI. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 2008;13:1003-1017. (Pubitemid 351594744)
22. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121:2465-2472. (Pubitemid 350022416)
23. Casparie M, Tiebosch AT, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007;29:19-24. (Pubitemid 46535194)
24. van Zeeburg HJ, Snijders PJ, Pals G, et al. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. Cancer Res 2005;65:1271-1276. (Pubitemid 40270153)
25. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990;71 (Pt 1):173-181. (Pubitemid 20046022)
26. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002;40:779-787. (Pubitemid 34208623)
27. Snijders PJ, van Duin M, Walboomers JM, et al. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res 1998;58:3812-3818. (Pubitemid 28405635)
28. Lewis JS Jr. p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 2012;6 Suppl 1:S75-S82.
29. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002;161:1051-1060. (Pubitemid 34988393)
30. van de Wiel MA, Brosens R, Eilers PH et al. Smoothing waves in array CGH tumor profiles. Bioinformatics. 2009;25:1099-1104.
31. van de Wiel MA, Kim KI, Vosse SJ et al. CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics. 2007;23:892-894. (Pubitemid 47049924)
32. Ostrovnaya I, Seshan VE, Begg CB. Comparison of properties of tests for assessing tumor clonality. Biometrics 2008;64:1018-1022.
33. Ostrovnaya I, Seshan VE, Olshen AB, Begg CB. Clonality: an R package for testing clonal relatedness of two tumors from the same patient based on their genomic profiles. Bioinformatics 2011;27:1698-1699.
34. Coissard CJ, Besson G, Polette MC, Monteau M, Birembaut PL, Clavel CE. Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 2005;18:1606-1609. (Pubitemid 41670660)
35. Galvan A, Noci S, Taverna F, et al. Testing of human papillomavirus in lung cancer and non-tumor lung tissue. BMC Cancer 2012;12:512.
36. Travis WD, Brambilla E, Muller-Hermelink KM. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: International Agency for Research on Cancer, 2004.
37. Baba M, Castillo A, Koriyama C, et al. Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas. Oncol Rep 2010;23:1085-1092.
38. Kato T, Koriyama C, Khan N, et al. EGFR mutations and human papillomavirus in lung cancer. Lung Cancer 2012;78:144-147.
39. Lorenzon L, Benevolo M, Visca P, et al. Human papillomavirus type 16 DNA detected in pulmonary metastases from a penile squamous cell carcinoma: a case study. Int J Surg Pathol 2013;21:59-62.
40. Weichert W, Schewe C, Denkert C, Morawietz L, Dietel M, Petersen I. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung. Am J Surg Pathol 2009;33:513-520.
41. Claas EC, Melchers WJ, van der Linden HC, Lindeman J, Quint WG. Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am J Pathol 1989;135:703-709. (Pubitemid 19268028)
42. Braakhuis BJ, Snijders PJ, Keune WJ, et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004;96:998-1006. (Pubitemid 39162642)
43. Will C, Schewe C, Schluns K, Petersen I. HPV typing and CGH analysis for the differentiation of primary and metastatic squamous cell carcinomas of the aerodigestive tract. Cell Oncol 2006;28:97-105. (Pubitemid 43999885)
44. Geurts TW, van Velthuysen ML, Broekman F, et al. Differential diagnosis of pulmonary carcinoma following head and neck cancer by genetic analysis. Clin Cancer Res 2009;15:980-985.
45. Gélinas JF, Manoukian J, Côté A. Lung involvement in juvenile onset recurrent respiratory papillomatosis: a systematic review of the literature. Int J Pediatr Otorhinolaryngol 2008;72:433-452.
46. Tryfon S, Dramba V, Zoglopitis F, et al. Solitary papillomas of the lower airways: epidemiological, clinical, and therapeutic data during a 22-year period and review of the literature. J Thorac Oncol 2012;7:643-648.
47. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 1998;108:735-740. (Pubitemid 28213498)
48. Reidy PM, Dedo HH, Rabah R, et al. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 2004;114:1906-1909. (Pubitemid 39539845)
49. Lele SM, Pou AM, Ventura K, Gatalica Z, Payne D. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. Arch Pathol Lab Med 2002;126:1184-1188. (Pubitemid 36240253)
50. Doyle DJ, Henderson LA, LeJeune FE Jr, Miller RH. Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm. Arch Otolaryngol Head Neck Surg 1994;120:1273-1276. (Pubitemid 24345772)
51. Yuan H, Myers S, Wang J, et al. Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med 2012;367:1220-1227.
52. Byrne JC, Tsao MS, Fraser RS, Howley PM. Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 1987;317:873-878. (Pubitemid 17160540)